Hepatitis B e antigen (HBeAg) occurs in the serum of individuals infected with hepatitis B virus both free and in association with IgG. Utilizing a succession of steps involving salt precipitation, affinity chromatography, ion-exchange chromatography and isoelectrofocusing, we isolated free and IgG-bound forms of HBeAg from the sera of infected individuals with an overall gain in specific activity of 3ooo-fold and 54o-fold, respectively. Polypeptide profiles of purified HBeAg preparations were studied by SDS-polyacrylamide gel electrophoresis in the presence of 2-mercaptoethanol. Both free and IgG-bound preparations revealed polypeptides with mol. wt. of 15500 (PI5"5) and 1650o (PI6"5), and HBeAg activity was detected corresponding to their positions. The HBeAg polypeptides (PI5.5/16"5) derived from sera were physicochemically different from the two polypeptides with HBeAg activity (PI9 and P45) liberated from Dane particle cores by the conventional method involving incubation with Nonidet P4 o and 2-mercaptoethanol. However, when core particles were prepared in the presence of a proteolytic enzyme, in addition to Nonidet P4 o and 2-mercaptoethanol, they gave rise to HBeAg polypeptides with mol. wt. of 3 r ooo (P3 I) and 15500. Furthermore, P31 split into PI5" 5 when heated at IOO °C for 2 rain. On the basis of these results, PI5"5 may be assumed to be the essential polypeptide bearing HBeAg activity in the serum and also in Dane particles.
INTRODUCTION
Up to the present, three antigens have been identified in the serum of persons infected with hepatitis B virus (HBV). They are hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg) and hepatitis B e antigen (HBeAg) (Blumberg et aL I965; Almeida et al. I97I ; Magnius & Espmark, I97Z) . Recent attention has been focused on HBeAg because of increasing lines of evidence which gave it enormous implication in virological, clinical and epidemiological settings (Nielsen et aL 1974; Feinman et aL I975; Okada et al. I976) . In a previous paper, we reported that HBeAg is an integral component of Dane particles (Dane et al. I97O) , the accepted hepatitis B virions, and described HBeAg polypeptides with tool. wt. of 19oo0 (PI9) and 45000 (P45) (Takahashi et al. ~979a) .
In the serum of individuals infected with HBV, HBeAg occurs both free and in association with IgG (Takahashi et al. I978a) . We have isolated free and IgG-bound forms of HBeAg oo22-I317/8o/oooo-4~14 $02.00 © I98o SGM separately from sera of infected individuals and looked for polypeptides bearing HBeAg activity. The present paper provides an account of polypeptides with HBeAg activity derived from the sera of HBV carriers and also of their relation with HBeAg polypeptides contained in Dane particles.
METHODS
Serological tests. HBeAg was determined by the inhibition of passive haemagglutination. The test sample was serially diluted in a microtitre plate and two haemagglutinating units of antibody to HBeAg (anti-HBe) were added. After incubating the plate at 37 °C for I h, sheep red blood cells which had been fixed with glutaraldehyde and coated with purified HBeAg were added. The plate was allowed to stand at room temperature for I h and the pattern of haemagglutination was read. The result was expressed by the highest dilution of the sample that inhibited haemagglutination. HBsAg and antibody to HBsAg (anti-HBs) were determined by passive haemagglutination (Vyas & Shulman, I97O) , HBcAg and antibody to HBcAg (anti-HBc) by immune adherence haemagglutination (Tsuda et al. ~975) and anti-HBe by passive haemagglutination (Takahashi et aL I978b) .
Preparation of free and IgG-bound HBeAg from sera. Sera of symptom-free carriers of HBV with high HBeAg titres were selected. They were mixed to make a 3 1 pool with an overall HBeAg titre of 2 G. The serum pool was precipitated by making 1.33 M with (NH4)~SO a. Free HBeAg stayed in the supernatant, while IgG-bound HBeAg precipitated. The supernatant containing free HBeAg was made z M with (NH~)2SO ~ and centrifuged. The precipitate formed was solubilized with a portion of distilled water, dialysed against o'oI M-tris-HCl buffer (pH 7"6), containing o.I M-NaC1, and subjected to gel filtration on Sephadex G-2oo. Fractions were monitored for HBeAg by the haemagglutination method and only those containing a high activity for HBeAg were collected. They were subjected to an affinity column of anti-HBe (Takahashi et al. I978b) . After washing the column extensively with buffer, bound HBeAg was dissociated by 3 M-NaI. The eluate was extensively dialysed against buffer and finally subjected to an ion-exchange chromatography on DEAESephadex A-5o. Fractions with high HBeAg activity were pooled, concentrated and served as a free HBeAg preparation for the study of polypeptide compositions. At the final step of purification, a gain in specific activity (HBeAg titre/A28o value) by approx. 3ooo-fold as compared with the original serum pool was achieved.
For the preparation of IgG-bound HBeAg, the precipitate of sera made to 1.33 M with (NH4)2SO 4 was dissolved in a portion of water and extensively dialysed against tris-HC1 buffer. The solution was subjected to the affinity column of anti-HBe. After washing the column extensively with buffer and o'5 M-NaI, IgG-bound HBeAg was dissociated by 3 MNaI. The eluate was dialysed against buffer and subjected to isoelectrofocusing according to the method described previously (Takahashi et aL 1978a) . Only the fractions with a pI value at around 5"7 which contained IgG-bound HBeAg were collected. They were concentrated and used as an IgG-bound HBeAg preparation with a specific activity 54o-fold higher than that of the original serum pool.
When purified preparations containing free and IgG-bound HBeAg were studied by disc electr0phoresis in polyacrylamide according to the method described elsewhere (Takahashi et al. I979b) , they were fairly homogeneous in electrophoretie mobility.
Dane particles and their cores. Dane particles were obtained from pooled plasma of symptom-free carriers of HBV by the method of Takahashi et aL (1976) involving concentration by pelleting and repeated ultracentrifugation, but with some modification. The treatment of Dane particles with Pronase (Kaken Chemical Co. Ltd., Tokyo, Japan) in the original method was omitted in order to keep their surfaces intact. Core particles were prepared from Dane particles by two different methods. Cores were obtained by incubating Dane particles at 37 °C for 2 h, either with I ~ Nonidet P4o and o.I ~ 2-mercaptoethanol, or in the presence of o.I mg/ml of Pronase, in addition to these reagents. These two kinds of procedure gave rise to core particles which were morphologically different. Core particles prepared in the presence of Pronase were somewhat smaller in diameter than those obtained without Pronase (mean diam. of 5o particles 25-I compared with 26.8 nm), indicating that some molecules of a protein nature coating core particles had been removed by the enzyme.
A solution of core particles prepared with Pronase (HBcAg titre 211) was mixed with an equal volume of the buffer containing o.2 ~ Nonidet P4o, o.2 ~ 2-mercaptoethanol and 0.2 mg/ml of Pronase, and incubated at 37 °C for 2 h. Five hundred #I of this preparation were applied to the surface of a linear sucrose gradient (25 to 6o ~) prepared in a tube for a Beckman SW65 rotor (capacity 5"5 ml) and centrifuged at 6o ooo rev/min for 3 h. The tube was pierced at the bottom and o.2 ml fractions were collected. They were scanned for HBcAg and HBeAg by haemagglutination methods, as well as for density by refractometry. Dane particle cores withyarying density thus obtained were subjected to SDS-polyacrylamide gel electrophoresis for the study of polypeptide composition.
SDS-polyaerylamide gel electrophoresis.
Ninety #1 of purified HBeAg preparation were mixed with IO/~1 of the buffer containing IO ~ SDS and Io ~ mercaptoethanol and incubated at 37 °C for z h. They were subjected to polyacrylamide gel electrophoresis in a Hoeffer SD 5oo apparatus (Hoeffer Scientific Instruments, San Francisco, Calif., U.S.A.) between two glass plates (I2o x I4o ram) standing vertically I'5 mm apart. The details of electrophoresis have been described elsewhere (Takahashi et al. I979a ) . A test sample was run simultaneously in two positions. After electrophoresis, the gel strip was cut into half so that each contained one run for the sample, one of which was sliced at I mm, eluted with a portion of buffer and tested for HBeAg by the inhibition of passive haemagglutination. The other was stained with Coomassie brilliant blue for the estimation of mol. wt. of polypeptides. In a similar manner, preparations containing Dane particle cores were incubated at 37 °C for 2 h in the presence of I ~oo SDS and I ~ 2-mercaptoethanol and subjected to SDS-polyacrylamide gel electrophoresis. The following were used as references to estimate the tool. wt. of polypeptides: human serum albumin, catalase, lactic dehydrogenase and lysozyme.
Immunization. Nine-tenth #1 of Dane particle preparation (A280 of I'5) was mixed with oq ml of a solution containing IO ~ SDS and IO ~ 2-mercaptoethanol, incubated at 37 °C for 2 h and then emulsified in 2 ml of complete Freund's adjuvant. A male albino rabbit received 3 ml of the inoculum subcutaneously and in hind footpads. Four weeks later, the rabbit was boosted with 3 ml of the same inoculum and exsanguinated after 2 weeks. Antiserum was tested for anti-HBs, anti-HBc and anti-HBe by haemagglutination methods and also by Ouchterlony double-immunodiffusion tests. The gel for immunodiffusion consisted of 0"9 ~ agarose dissolved in a solution containing o.oI M-tris, o't M-NaC1, 2 ~oo dextran T-5oo, 2 ~ polyethylene glycol (6ooo), o-I ~ NaN~ and 0"74 ~o EDTA-Na., which had been adjusted to pH 7"6 by NaOH.
RESULTS

HBeAg polypeptides derived from free and IgG-bound HBeAg preparations
Free 'small' and IgG-bound 'large' HBeAg which had been purified from sera of symptom-flee carriers of HBV, were subjected to SDS-polyacrylamide gel electrophoresis The polypeptide profile of free HBeAg is given in Fig. I 
HBeAg polypeptides derived from Dane particle cores
Dane particle cores which had been prepared in the presence of Pronase were fractionated by ultracentrifugation in a sucrose density gradient with the results given in Fig. 3 . Core particles as represented by HBcAg activity distributed over the sucrose density ranging from 31 to 43 %. Some HBeAg activity was detected in fractions at lower density, peaking at z 5 ~o sucrose. Fractions indicated by C to F were subjected to SDS-polyacrylamide gel electrophoresis. The pattern of core particles recovered at a higher density (D, 36 % sucrose) and 53 that of those obtained at a lower density (F, 33 ~ sucrose) are shown in Fig. 4 . Core particles with a higher density disclosed three major polypeptides. The largest polypeptide appeared at a position corresponding to mol. wt. of 31 ooo and the other two at the position of PI5"5/I6"5. HBeAg activity was observed corresponding to all these polypeptides. In contrast, core particles with a lower density revealed two major polypeptides at positions of mol. wt. 3I ooo and I55OO, both of which were associated with HBeAg activity. When the 3 t ooo mol. wt. HBeAg polypeptide was heated at I oo °C for 2 min and then subjected to SDS-polyacrylamide gel electrophoresis, all the HBeAg activity migrated to the position of tool. wt. 155o0. These results indicated that 3tooo tool. wt. HBeAg activity most likely represented the dimer of 15500 tool. wt. HBeAg polypeptide.
In Fig. 5 polypeptide profiles of IgG-bound HBeAg in the serum (A), Dane particle cores prepared in the absence of Pronase (B) and four preparations containing core particles with varying density prepared in the presence of Pronase (C to F) are shown for comparison. HBeAg activity in core particles obtained in the absence of Pronase disclosed two polypeptides, Pt9 and P45, both of which were associated with HBeAg activity (Takahashi et al. 1979a ).
Immunogenicity of Dane particles
A rabbit which had been inoculated with a Dane particle preparation raised antibodies against HBsAg, HBcAg and HBeAg. The titres of anti-HBs, anti-HBc and anti-HBe were 27, 98 and 28 at 4 weeks after the initial inoculation and increased after booster injection up to 21°, 212 and z n, respectively. 
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DISCUSSION
Despite its practical value as a marker of infectivity and prognosis, the exact nature of HBeAg has remained unclear. We have tried to sort out the relation between HBeAg and Dane particles, the presently accepted HBV. In a previous paper, cores were obtained by incubating Dane particles with Nonidet P4o and 2-mercaptoethanol for the study of constituent polypeptides. Dane particle cores thus prepared revealed two major polypeptides with apparent tool. wt. of I9OOO and 45ooo (PI9 and P45), both of which presented a strong activity of HBeAg (Takahashi et al. ~979a ). The conclusion was drawn, accordingly, that HBeAg was indeed a polypeptide contained in hepatitis B virion nucleocapsid. This view was strengthened by the present finding that a rabbit inoculated with Dane particles raised antiHBe, in addition to anti-HBs and anti-HBc. Although not tested for in the present experiment, it would be worth seeing whether the rabbit had elicited antibodies against 8 antigen described by Rizzetto et aL (I977) .
Since HBeAg occurs both in Dane particles and in the serum of infected individuals, it would be worth characterizing polypeptides with HBeAg activity in the serum and comparing them with polypeptides of Dane particle cores. HBeAg occurs in the serum of individuals carrying HBV both free and in association with IgG (Takahashi et aL ~978a). Free and IgG-bound forms of HBeAg were purified separately in substantial quantities, and their polypeptides with HBeAg activity studied. Both free and IgG-bound forms of HBeAg revealed two polypeptides with apparent mol. wt. of 15 5 °o and 16 5oo. HBeAg activity was found at the position of these two polypeptides (PI5.5/I6.5). Due to close similarity in mol. wt. and the limitation of the haemagglutination method in quantifying HBeAg activity, it was not possible to ascribe HBeAg activity to either or both of these polypeptides.
HBeAg polypeptides derived from the serum were substantially different in size from the two polypeptides with HBeAg activity contained in Dane particles, PI9 and P45, described previously. Since HBeAg in the serum and in Dane particles were reasonably assumed to share the same ligand, we tried to obtain smaller HBeAg polypeptides from Dane particle cores. The core of Dane particles seemed to be composed mainly of HBeAg polypeptides (Pr 9 and P45) covered with a thin layer of molecules with HBcAg activity (Takahashi et aL  x979 a) . The cores were first treated with a proteolytic enzyme, with the intention of peeling off the protein coat beforehand, and were then broken into polypeptides by SDS and 2-mercaptoethanol. Dane particle cores prepared with Pronase were smaller in diameter (25.r as against 26.8 nm) and lighter in density [3I to 43 ~ versus 47 to 54 ~ sucrose (Takahashi et al. I976) ] than those obtained without the proteolytic enzyme. They spread over a wide range of fractions on ultracentrifugation in a sucrose density gradient.
Core particles with a higher density disclosed PI5"5/I6"5 which were thought to be identical to HBeAg polypeptides derived from the serum. Core particles with a lower density, however, revealed two major polypeptides at the position of mol. wt. 3~ ooo and I55oo, both of which were associated with HBeAg activity. Since the 3IOOO tool. wt. polypeptide split into PI5. 5 by heating, it probably represents the dimer of PI5"5. It can naturally be assumed from these results that at least P I 5"5 of P I 5"5/I 6"5 in the serum bears HBeAg activity. McAuliffe & Purcell (I978) as well as Tedder & Bull 0979) have reported HBeAg polypeptides with an approx, mot. wt. of I7ooo, which seem to be relevant to PI5"5 or PI5"5/t6"5 in our experiments.
The fact that HBeAg in circulation and Dane particle cores shared a polypeptide with HBeAg activity (PI5.5) provides the basis to assume that circulating HBeAg would be a polypeptide of virus origin coded by the genome of HBV. Recent advances in gene technology have been successfully applied to the analysis of HBV-associated molecules. If the sequence of several amino acids from both amino-and carboxyl-terminals were determined for PI5"5, the exact and whole amino acid sequence of HBeAg polypeptide will be readily uncoded on the HBV-specific DNA, just as demonstrated for the major HBsAg polypeptide by Valenzuela et al. (I979) .
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